Regional
Regional Emergency Medical Advisory Committee of New York City
Regional Emergency Medical Advisory Committee of New York City (New York City, NY) carries 40 drugs across 137 dose entries in its current published protocol, effective 2026-08-01.
Drugs and doses40
Acetaminophen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 15 mg/kg (max 1000 mg) | IV/PO | not captured | standing | page 95 |
| Mild to moderate pain | peds | 15 mg/kg (max 1000 mg) | IV/PO | not captured | standing | page 95 |
Adenosine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| SVT | adult | 6 mg | IV | not captured | standing | page 59 |
| SVT | peds | 0.1 mg/kg | IV | not captured | standing | page 59 |
Albuterol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 3 mL | NEB | not captured | standing | page 48 |
| Anaphylaxis | peds | 3 mL | NEB | not captured | standing | page 48 |
| Asthma / bronchospasm | adult | 3 mL | NEB | not captured | standing | page 71 |
| Asthma / bronchospasm | peds | 3 mL | NEB | not captured | standing | page 71 |
Amiodarone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Atrial fibrillation with RVR | adult | 150 mg | IV | not captured | standing | page 57 |
| Other | adult | 150 mg | IV | not captured | standing | page 60 |
| VF / pulseless VT | adult | 300 mg | IV | not captured | standing | page 35 |
| VF / pulseless VT | peds | 5 mg/kg | IV | not captured | standing | page 35 |
Aspirin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 324 mg | PO | not captured | standing | page 54 |
Atropine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 1 mg | IV | not captured | standing | page 58 |
| Bradycardia | peds | 0.02 mg/kg | IV | not captured | standing | page 39 |
| Nerve agent exposure | peds | 0.5 mg | IM | not captured | standing | page 121 |
Calcium Chloride
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperkalemia | adult | 1 g | IV | not captured | standing | page 36 |
| Hyperkalemia | peds | 20 mg/kg | IV | not captured | standing | page 36 |
Dexamethasone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 0.6 mg/kg | IV/IM/PO | not captured | standing | page 49 |
| Anaphylaxis | peds | 0.6 mg/kg | IV/IM/PO | not captured | standing | page 49 |
| Asthma / bronchospasm | adult | 0.6 mg/kg | IV/IM/PO | not captured | standing | page 72 |
| Asthma / bronchospasm | peds | 0.6 mg/kg | IV/IM/PO | not captured | standing | page 72 |
| Croup | adult | 0.6 mg/kg | IV/IM/PO | not captured | standing | page 74 |
| Croup | peds | 0.6 mg/kg | IV/IM/PO | not captured | standing | page 74 |
Dextrose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | peds | 0.5 g/kg | IV | not captured | standing | page 37 |
| Neonatal resuscitation | peds | 0.5 g/kg | IV | not captured | standing | page 69 |
| Other | adult | 25 g | IV | not captured | standing | page 46 |
| Other | peds | 0.5 g/kg | IV | not captured | standing | page 46 |
Diazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperactive delirium | adult | 0.2 mg/kg | IV/IM/IN | not captured | standing | page 52 |
| Other | adult | 0.2 mg/kg | IV | not captured | standing | page 98 |
| Procedural sedation | adult | 0.1 mg/kg | IV | not captured | standing | page 98 |
| Seizure | adult | 0.2 mg/kg | IV | not captured | standing | page 84 |
| Seizure | peds | 0.2 mg/kg | IV | not captured | standing | page 84 |
Diltiazem
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Atrial fibrillation with RVR | adult | 0.25 mg/kg | IV | not captured | standing | page 57 |
| Narrow-complex tachycardia | adult | 0.25 mg/kg | IV | not captured | standing | page 59 |
Diphenhydramine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 1 mg/kg | IV/IM | not captured | standing | page 49 |
| Anaphylaxis | peds | 1 mg/kg | IV/IM | not captured | standing | page 49 |
| Dystonic reaction | adult | 1 mg/kg | IV/IM | not captured | standing | page 82 |
| Dystonic reaction | peds | 1 mg/kg | IV/IM | not captured | standing | page 82 |
Dopamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 5 mcg/kg | IV | not captured | standing | page 58 |
Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 0.3 mg | IM | not captured | standing | page 48 |
| Anaphylaxis | peds | 0.15 mg | IM | not captured | standing | page 48 |
| Bradycardia | peds | 0.01 mg/kg | IV | not captured | standing | page 39 |
| Cardiac arrest | adult | 1 mg | IV | not captured | standing | page 35 |
| Cardiac arrest | peds | 0.01 mg/kg | IV | not captured | standing | page 35 |
| Hypotension / shock | adult | 10 mcg | IV | not captured | standing | page 87 |
| Hypotension / shock | peds | 5 mcg | IV | not captured | standing | page 87 |
| Respiratory distress | peds | 0.01 mg/kg | IM | not captured | standing | page 72 |
| Stridor | peds | 3 mg | NEB | not captured | standing | page 74 |
| Stridor | peds | 3 mg | NEB | not captured | standing | page 74 |
Etomidate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.3 mg/kg (max 40 mg) | IV | not captured | standing | page 98 |
| Procedural sedation | adult | 0.15 mg/kg (max 20 mg) | IV | not captured | standing | page 98 |
Fentanyl
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 mcg/kg (max 100 mcg) | IV | not captured | standing | page 98 |
| Mild to moderate pain | adult | 1 mcg/kg (max 100 mcg) | IV/IM/IN | not captured | standing | page 95 |
| Mild to moderate pain | peds | 1 mcg/kg (max 100 mcg) | IV/IM/IN | not captured | standing | page 95 |
Furosemide
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Respiratory distress | adult | 20–80 mg | IV | not captured | standing | page 42 |
Glucagon
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 mg | IM/IN | not captured | standing | page 46 |
| Other | peds | 1 mg | IM/IN | not captured | standing | page 46 |
Hydroxocobalamin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cyanide poisoning | adult | 5 g | IV | not captured | standing | page 119 |
| Cyanide poisoning | peds | 75 mg/kg | IV | not captured | standing | page 119 |
Ipratropium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 2.5 mL | NEB | not captured | standing | page 48 |
| Anaphylaxis | peds | 2.5 mL | NEB | not captured | standing | page 48 |
| Asthma / bronchospasm | adult | 2.5 mL | NEB | not captured | standing | page 71 |
| Asthma / bronchospasm | peds | 2.5 mL | NEB | not captured | standing | page 71 |
Ketamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperactive delirium | adult | 2–4 mg/kg | IM | not captured | standing | page 52 |
| Hyperactive delirium | peds | 2–4 mg/kg | IM | not captured | standing | page 52 |
| Other | adult | 1 mg/kg | IV | not captured | standing | page 98 |
| Other | adult | 2 mg/kg | IV | not captured | standing | page 98 |
| Mild to moderate pain | adult | 0.2 mg/kg | IV | not captured | standing | page 96 |
| Mild to moderate pain | adult | 0.4 mg/kg | IM/IN | not captured | standing | page 96 |
| Mild to moderate pain | peds | 0.2 mg/kg | IV | not captured | standing | page 96 |
| Mild to moderate pain | peds | 0.4 mg/kg | IM/IN | not captured | standing | page 96 |
| Procedural sedation | adult | 1 mg/kg | IV | not captured | standing | page 98 |
Ketorolac
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 15 mg | IV/IM | not captured | standing | page 95 |
Lidocaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 0.5 mg/kg | IO | not captured | standing | page 19 |
| Mild to moderate pain | peds | 0.5 mg/kg | IO | not captured | standing | page 19 |
| Wide-complex tachycardia | adult | 1 mg/kg | IV | not captured | standing | page 60 |
| VF / pulseless VT | adult | 100 mg | IV | not captured | standing | page 35 |
| VF / pulseless VT | peds | 1 mg/kg | IV | not captured | standing | page 35 |
Lorazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperactive delirium | adult | 0.1 mg/kg | IM | not captured | standing | page 52 |
| Hyperactive delirium | adult | 0.1 mg/kg | IV/IN | not captured | standing | page 52 |
| Hyperactive delirium | peds | 0.1 mg/kg | IM | not captured | standing | page 52 |
| Hyperactive delirium | peds | 0.1 mg/kg | IV/IN | not captured | standing | page 52 |
| Other | adult | 0.1 mg/kg | IV | not captured | standing | page 98 |
| Procedural sedation | adult | 0.02 mg/kg | IV | not captured | standing | page 98 |
| Seizure | adult | 0.1 mg/kg | IV/IM/IN | not captured | standing | page 84 |
| Seizure | peds | 0.1 mg/kg | IV/IM/IN | not captured | standing | page 84 |
Magnesium Sulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 2 g | IV | not captured | standing | page 72 |
| Asthma / bronchospasm | peds | 50 mg/kg | IV | not captured | standing | page 72 |
| Eclampsia / pre-eclampsia | adult | 4 g | IV | not captured | standing | page 63 |
| Wide-complex tachycardia | adult | 2 g | IV | not captured | standing | page 60 |
| VF / pulseless VT | adult | 2 g | IV | not captured | standing | page 36 |
| VF / pulseless VT | peds | 25–50 mg/kg | IV | not captured | standing | page 36 |
Methylprednisolone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 1 mg/kg | IV/IM | not captured | standing | page 49 |
| Anaphylaxis | peds | 1 mg/kg | IV/IM | not captured | standing | page 49 |
| Asthma / bronchospasm | adult | 1 mg/kg | IV/IM | not captured | standing | page 72 |
| Asthma / bronchospasm | peds | 1 mg/kg | IV/IM | not captured | standing | page 72 |
| Croup | peds | 1 mg/kg | IV/IM | not captured | standing | page 74 |
Metoprolol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Stroke | adult | 5 mg | IV | not captured | standing | page 90 |
Midazolam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperactive delirium | adult | 0.2 mg/kg | IM/IN | not captured | standing | page 51 |
| Hyperactive delirium | adult | 0.2 mg/kg | IV | not captured | standing | page 51 |
| Hyperactive delirium | peds | 0.1 mg/kg | IM/IN | not captured | standing | page 51 |
| Hyperactive delirium | peds | 0.1 mg/kg | IV | not captured | standing | page 51 |
| Nerve agent exposure | peds | 0.2 mg/kg | IM | not captured | standing | page 123 |
| Other | adult | 0.2 mg/kg | IV | not captured | standing | page 98 |
| Procedural sedation | adult | 0.1 mg/kg | IV | not captured | standing | page 98 |
| Seizure | adult | 0.2 mg/kg | IV/IM/IN | not captured | standing | page 84 |
| Seizure | peds | 0.2 mg/kg | IV/IM/IN | not captured | standing | page 84 |
Morphine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 0.1 mg/kg (max 5 mg) | IV/IM | not captured | standing | page 95 |
| Mild to moderate pain | peds | 0.1 mg/kg (max 5 mg) | IV/IM | not captured | standing | page 95 |
Naak
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nerve agent exposure | adult | 3 unit | IM | not captured | standing | page 121 |
| Nerve agent exposure | peds | 1–2 unit | IM | not captured | standing | page 121 |
Naloxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Opioid overdose | adult | 1 mg | IN | not captured | standing | page 81 |
| Opioid overdose | adult | 0.5 mg | IV/IM/IN | not captured | standing | page 82 |
| Opioid overdose | peds | 0.5 mg | IN | not captured | standing | page 81 |
| Opioid overdose | peds | 0.5 mg | IV/IM/IN | not captured | standing | page 82 |
Nitroglycerin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 0.4 mg | SL | not captured | standing | page 54 |
| CHF / pulmonary edema | adult | 0.4 mg | IV/SL | not captured | standing | page 42 |
Norepinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypotension / shock | adult | 2 mcg | IV | not captured | standing | page 87 |
| Hypotension / shock | peds | 0.05 mcg/kg | IV | not captured | standing | page 87 |
| Sepsis | adult | 2 mcg | IV | not captured | standing | page 87 |
| Sepsis | peds | 0.05 mcg/kg | IV | not captured | standing | page 87 |
Ondansetron
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 0.1 mg/kg (max 8 mg) | IV/IM/PO | not captured | standing | page 92 |
| Nausea / vomiting | peds | 0.1 mg/kg (max 8 mg) | IV/IM/PO | not captured | standing | page 92 |
Proparacaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.5% 1-2 gtts | TOP | not captured | standing | page 112 |
| Other | peds | 0.5% 1-2 gtts | TOP | not captured | standing | page 112 |
Racemic Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Stridor | peds | 0.5 mL | NEB | not captured | standing | page 74 |
Sodium Bicarbonate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 44–88 mEq | IV | not captured | standing | page 58 |
| Hyperkalemia | adult | 44–88 mEq | IV | not captured | standing | page 36 |
| Hyperkalemia | peds | 1 mEq/kg | IV | not captured | standing | page 36 |
| Wide-complex tachycardia | adult | 44–88 mEq | IV | not captured | standing | page 60 |
Sodium Thiosulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cyanide poisoning | adult | 12.5 g | IV | not captured | standing | page 119 |
| Cyanide poisoning | peds | 250 mg/kg | IV | not captured | standing | page 119 |
Tetracaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.5% 1-2 gtts | TOP | not captured | standing | page 112 |
| Other | peds | 0.5% 1-2 gtts | TOP | not captured | standing | page 112 |
Vasopressin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypotension / shock | adult | 0.02 unit | IV | not captured | standing | page 88 |
| Sepsis | adult | 0.02 unit | IV | not captured | standing | page 87 |